Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।
CURIN 5MG is indicated for:
-
Management of overactive bladder (OAB).
-
Reduction of urinary urgency, frequency, and incontinence.
Pharmacology
Solifenacin Succinate is a competitive muscarinic receptor antagonist that decreases bladder muscle activity, thereby reducing the symptoms of overactive bladder.
Dosage and Administration
-
The usual dose is 5 mg once daily, taken orally.
-
Can be taken with or without food.
-
Dosage may be increased to 10 mg daily if necessary and tolerated.
Interaction
-
Use cautiously with other anticholinergic drugs to avoid additive effects.
-
May interact with CYP3A4 inhibitors like ketoconazole, increasing solifenacin levels.
-
Avoid use with QT-prolonging medications to reduce arrhythmia risk.
Contraindications
-
Hypersensitivity to Solifenacin or any ingredient in the formulation.
-
Urinary retention, uncontrolled narrow-angle glaucoma, or severe gastrointestinal conditions like paralytic ileus.
Side Effects
-
Common: Dry mouth, constipation, blurred vision, and drowsiness.
-
Rare: Severe allergic reactions, urinary retention, or palpitations.
Pregnancy & Lactation
-
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.
-
Not recommended during breastfeeding unless clearly necessary.
Precautions & Warnings
-
Use with caution in patients with renal or hepatic impairment.
-
Avoid activities requiring mental alertness if dizziness or drowsiness occurs.
-
Ensure adequate hydration to prevent constipation or dry mouth.
Therapeutic Class
Antimuscarinic agent for overactive bladder.
Storage Conditions
Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.
 15050160.jpg)
 350ML.jpg)
 60 ML.jpg)
 100 IU.jpg)
.jpg)
 100 IU.jpg)
 10025 100 MG 25 MG.jpg)
 400MG.jpg)
 30PCS.jpg)
 20025 20025.jpg)
.jpg)
 350ML.jpg)
Change Language